The Montreal Clinical Research Institute (IRCM) pays tribute to the memory of Dr. Max Fehlmann, who headed the IRCM from 2019 to 2021.
‘’We salute a man who has worked to advance scientific innovation in many capacities, including at IRCM,” said Dr. Jean-François Côté, President and Scientific Director of IRCM.
Dr. Fehlmann was President and CEO of the Cancer Research Society. He was also founding President and CEO of the NÉOMED Institute, and founding President and CEO of CQDM, a Montreal-based pre-competitive research consortium. He has worked in the scientific and pharmaceutical fields for many years.
Our thoughts are with his family at this difficult time.
